SCHEMBL3412017

SCHEMBL3412017

Nc1cnccc1N(C(=O)O)C1CCCNC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPLP1 P05386 10/20 0.41
RPLP0 P05388 10/20 0.41
RPS17 P08708 10/20 0.41
RPSA P08865 10/20 0.41
RPS2 P15880 10/20 0.41
RPL35A P18077 10/20 0.41
RPL7 P18124 10/20 0.41
RPL17 P18621 10/20 0.41
RPS4Y1 P22090 10/20 0.41
RPS3 P23396 10/20 0.41
RPS12 P25398 10/20 0.41
RPL13 P26373 10/20 0.41
RPL10 P27635 10/20 0.41
RPL12 P30050 10/20 0.41
RPL9; RPL9P7; RPL9P8; RPL9P9 P32969 10/20 0.41
RPL22 P35268 10/20 0.41
RPL4 P36578 10/20 0.41
RPS19 P39019 10/20 0.41
RPL3 P39023 10/20 0.41
RPL13A P40429 10/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4436048 0.84 RPLP1 (0.36) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL3410670 0.84 RPLP1 (0.36) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL3410672 0.84 RPLP1 (0.36) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL8223035 0.81 PCSK9 (0.37) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL3408546 0.81 MEN1 (0.39) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL17440453 0.80 RPLP1 (0.44) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL3415524 0.80 KDM4E (0.38) KCNH2KDM4EMEN1KDM6BKDM4A
SCHEMBL3406173 0.80 KDM4E (0.38) KCNH2KDM4EMEN1KDM6BKDM4A
SCHEMBL3406178 0.80 KDM4E (0.38) KCNH2KDM4EMEN1KDM6BKDM4A
SCHEMBL3410722 0.79 KDM4E (0.39) KDM4EMEN1KDM6BKDM4AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016010897-A1 BICYCLIC HETEROAROMATIC CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE CORPORATION (US) 2016-01-21 WO disclosed
EP-2475659-A1 4-SUBSTITUTED PYRIDIN-3-YL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE F. Hoffmann-La Roche AG (CH) 2012-07-18 EP disclosed
WO-2011029802-A1 4-SUBSTITUTED PYRIDIN-3-YL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2011-03-17 WO disclosed
EP-2262802-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE Novartis AG (CH) 2010-12-22 EP disclosed
WO-2009109576-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE NOVARTIS AG (CH) 2009-09-11 WO disclosed